These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7181497)

  • 21. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antistaphylococcal activity of rifampin with other antibiotics.
    Zinner SH; Lagast H; Klastersky J
    J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampin in the treatment of serious staphylococcal infections.
    Swanberg L; Tuazon CU
    Am J Med Sci; 1984; 287(3):49-54. PubMed ID: 6563847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
    Timbrook TT; McKay L; Sutton JD; Spivak ES
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
    Lorian V; Atkinson B; Kim Y
    Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The spread of oxacillin-resistant Staphylococcus aureus].
    Santini C; Baiocchi P; Venditti M; Serra P
    Recenti Prog Med; 1995 Feb; 86(2):78-80. PubMed ID: 7754178
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.
    Standiford HC; Walsh TJ; Drusano GL; Tatem BA; Townsend RJ
    Diagn Microbiol Infect Dis; 1993; 17(2):135-42. PubMed ID: 8243034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Bahl D; Miller DA; Leviton I; Gialanella P; Wolin MJ; Liu W; Perkins R; Miller MH
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1293-7. PubMed ID: 9174186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.
    Croes S; Beisser PS; Neef C; Bruggeman CA; Stobberingh EE
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3907-12. PubMed ID: 20606067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity of indolicidin, alone or together with oxacillin, against Staphylococcus aureus and S. epidermidis].
    Walencka E; Sadowska B; Wieckowska-Szakiel M; Rózalska B
    Med Dosw Mikrobiol; 2008; 60(3):191-6. PubMed ID: 19143172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
    Van der Auwera P; Klastersky J; Thys JP; Meunier-Carpentier F; Legrand JC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):467-72. PubMed ID: 3907494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of antibiotic treatment of implant-associated
    Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
    Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of bactericidal rate in the initial treatment of severe staphylococcal infections in children].
    Bingen E; Lambert-Zechovsky N; Beaufils F; Mercier JC; Cohen R; Roze JC
    Arch Fr Pediatr; 1988 Jan; 45(1):61-4. PubMed ID: 3365107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.